Anavex Life Sciences
AVXL
#7626
Rank
โ‚น34.58 B
Marketcap
โ‚น387.07
Share price
0.35%
Change (1 day)
-57.43%
Change (1 year)

Market capitalization of Anavex Life Sciences (AVXL)

Market cap: โ‚น34.58 Billion

As of January 2026 Anavex Life Sciences has a market cap of โ‚น34.58 Billion. This makes Anavex Life Sciences the world's 7626th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Anavex Life Sciences from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น34.58 B18.46%
2025โ‚น29.19 B-66.87%
2024โ‚น88.11 B38.5%
2023โ‚น63.62 B6.5%
2022โ‚น59.73 B-39.11%
2021โ‚น98.11 B271%
2020โ‚น26.44 B150.84%
2019โ‚น10.54 B106.13%
2018โ‚น5.11 B-43.75%
2017โ‚น9.09 B-14.71%
2016โ‚น10.65 B-16.9%
2015โ‚น12.82 B1896.21%
2014โ‚น0.64 B10.53%
2013โ‚น0.58 B-55.56%
2012โ‚น1.30 B-25.45%
2011โ‚น1.75 B-57.31%
2010โ‚น4.10 B96.05%
2009โ‚น2.09 B-15.24%
2008โ‚น2.47 B-39.15%
2007โ‚น4.06 B77%
2006โ‚น2.29 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Anavex Life Sciences was reported to be:

โ‚น34.46 Billion
by Nasdaq info icon info icon
โ‚น34.46 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น367.81 B 963.53%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น136.26 B 294.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น359.14 B 938.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น2.46 B-92.88%๐Ÿ‡บ๐Ÿ‡ธ USA